Novel neuropeptide Y receptor antagonists block vasoconstriction in the hamster cheek pouch microcirculation

Microvascular Research

Volumn 53, Issue 2, 1997, Pages 167-172

  Kim, Daekyung ^a   Durán, Walter T R ^a   Daniels, Alejandro J ^b   Durán, Walter N ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GR 231118; GW 383; NEUROPEPTIDE Y RECEPTOR; NEUROPEPTIDE Y RECEPTOR ANTAGONIST; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTERIOLE; ARTICLE; BLOOD PRESSURE; CHEEK; HAMSTER; HEMATOCRIT; MALE; MICROCIRCULATION; MICROVASCULATURE; NONHUMAN; PRIORITY JOURNAL; VASOCONSTRICTION;

EID: 0031105728     PISSN: 00262862     EISSN: None     Source Type: Journal    
DOI: 10.1006/mvre.1996.1991     Document Type: Article

References (22)

1. Armenante, P. M., Kim, D., and Durán, W. N. (1991). Experimental determination of the linear correlation between in vivo TV fluorescence and vascular and tissue FITC-dextran concentrations. Microvasc. Res. 42, 198-208.
2. Bekker, A. Y., Ritter, A. B., and Durán, W. N. (1989). Analysis of microvascular permeability to macromolecules by video-image digital processing. Microvasc. Res. 38, 200-216.
3. Borić, M. P., Martínez, A., Donoso, M. V., and Huidobro-Toro, J. P. (1995). Neuropeptide Y is a vasoconstrictor and adrenergic modulator in the hamster microcirculation by acting on neuropeptide Y1 and Y2 receptors. Eur. J. Pharmacol. 294, 391-401.
4. Daniels, A. J., Matthews, J. E., Slepetis, R. J., Marilyn Jansen, O., Viveros, O. H., Tadepalli, A., Harrington, W., Heyer, D., Landavzo, A., Leban, J. J., and Spaltenstein, A. (1995). High-affinity neuropeptide Y receptor antagonists. Proc. Natl. Acad. Sci. USA 92, 9067-9071.
5. Edvinsson, L. (1985). Characterization of the contractile effect of neuropeptide Y in feline cerebral arteries. Acta Physiol. Scand. 125, 33-41.
6. Ekblad, E., Edvinsson, L., Wahlestedt, C., Uddman, R., Håkanson, R., and Sundler, F. (1984). Neuropeptide Y co-exists and co-operates with noradrenaline in perivascular nerve fibers. Regul. Pept. 8, 225-235.
7. Glover, W. E. (1985). Increased sensitivity of rabbit ear artery to noradrenaline following perivascular nerve stimulation may be a response to neuropeptide Y released as cotransmitter. Clin. Exp. Pharmacol. Physiol. 12, 227-230.
8. Joyner, W. L., Campbell, G. T., Peterson, C., and Wagoner, J. (1983). Adrenergic neurons: Are they present on vessels in cheek pouches of hamsters?. Microvasc. Res. 26, 27-35.
9. Kim, D., Armenante, P. M., and Durán, W. N. (1993). Transient analysis of macromolecular transport across the microvascular wall and into the interstitium. Am. J. Physiol. 265, H993-H999.
10. Kim, D., Durán, W. R., Daniels, A. J., and Durán, W. N. (1994). Microcirculatory dynamics of neuropeptide Y. Microvasc. Res. 48, 124-134.
11. Komaru, T., Ashikawa, K., Kanatsuka, H., Sekiguchi, N., Suzuki, T., and Takishima, T. (1990). Neuropeptide Y modulates vasoconstriction in coronary microvessels in the beating canine heart. Circ. Res. 67, 1142-1151.
12. Lundberg, J. M., Terenius, L., Hökfelt, T., Martling, C. R., Tatemoto, K., Mutt, V., Polak, J., and Goldstein, M. (1982). Neuropeptide Y (NPY)-like immunoreactivity in peripheral noradrenergic neurons and effects of NPY on sympathetic function. Acta Physiol. Scand. 116, 477-480.
13. Lundberg, J. M., Änggård, A., Theodorsson-Norheim, E., and Pernow, P. (1984). Guanethidine-sensitive release of neuropeptide Y-like immunoreactivity in the cat spleen by sympathetic nerve stimulation. Neurosci. Lett. 52, 175-180.
14. 3H-noradrenaline and the contractile response evoked by field stimulation, in rat vas deferens. Acta Physiol. Scand. 120, 477-479.
15. Lundberg, J. M., Pernow, J., Tatemoto, K., and Dahlöf, C. (1985). Pre-and postjunctional effects of NPY on sympathetic control of rat femoral artery. Acta Physiol. Scand. 123, 511-513.
16. Lundberg, J. M., Rudehill, A., Sollevi A., Theodorsson-Norheim, E., and Hamberger, B. (1986). Frequency-and reserpine-dependent chemical coding of sympathetic transmission: Differential release of noradrenaline and neuropeptide Y from pig spleen. Neurosci. Lett. 63, 96-100.
17. Pernow, J., Saria, A., and Lundberg, J. M. (1986). Mechanisms underlying pre-and postjunctional effects of neuropeptide Y in sympathetic vascular control. Acta Physiol. Scand. 126, 239-249.
18. Potter, E. K. (1987). Presynaptic inhibition of cardiac vagal postganglionic nerves by neuropeptide Y. Neurosci. Lett. 83, 101-106.
19. Potter, E. K. (1988). Neuropeptide Y as an autonomic neurotransmitter. Pharmacol. Ther. 37, 251-273.
20. Schwartz, T. W., Fuhlendorff, J., Langeland, N., Thogersen, H., Jorgensen, J. C, and Sheikh, S. P. (1989). Y1 and Y2 receptors for neuropeptide Y: The evolution of PP-fold peptides and their receptors. In "Neuropeptide Y" (V. Mutt, Ed.), pp. 143-151. Raven Press, New York.
21. Sheikh, S. P., Håkanson, R., and Schwartz, T. W. (1989). Y1 and Y2 receptors for neuropeptide Y. FEBS Lett. 245, 209-214.
22. Tatemoto, K. (1982). Neuropeptide Y complete amino acid sequence of the peptide. Proc. Natl. Acad. Sci. USA 79, 5485-5489.